A New Product Pricing Model Using Intracorporate Market Perceptions to Extract the Value of Additional Information

Author： Woodward R.S.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.1, 1998-07, pp. : 71-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Value of Information and Pricing New Healthcare Interventions

By Willan Andrew R.  

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements

By Woodfield A.  

PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. : 365-377

Adis International

Access to resources Recommend Favorite

Edrecolomab: no additional value in colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Value-based pricing hot at ISPOR

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods

By Eckermann Simon  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 699-709

Adis International

Access to resources Recommend Favorite